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ABSTRACT
Background and Objectives: The identification of high-
stage and recurrent cases of bowel endometriosis is criti-
cal, because these cases require careful surgical planning.
We aim to describe the clinical characteristics of women
with bowel endometriosis, our principles in laparoscopic
management of this pathology, and to identify predictors
of severe disease and recurrence.
Methods: This was a retrospective study of 193 patients
with pathologically confirmed bowel endometriosis.
Results: Predictors of higher-stage endometriosis include
a history of previous laparoscopic surgery (P.04) and a
presenting complaint of abnormal uterine bleeding
(P.01). The higher the stage of endometriosis, the more
likely there would be coexistent urinary tract endometri-
osis (P.02), a need for enterolysis (P.002), ovarian
cystectomy (P.001), and bowel resection (P.01) per-
formed during laparoscopy. Patients with higher body
mass index (BMI) had significantly higher recurrence rates
of endometriosis compared to those with lower BMI
(P.002). Within our cohort, 87% of our patients achieved
amelioration of symptoms by the end of the first postop-
erative month.
Conclusions: Our study confirms that laparoscopic man-
agement of bowel endometriosis is safe and effective. We
found 2 statistically significant predictors of higher-stage
disease that should prompt careful surgical planning.
Obesity is associated with a higher rate of recurrence of
endometriosis.
Key Words: Laparoscopic surgery, Endometriosis, Bowel
endometriosis, Intestinal endometriosis.
INTRODUCTION
Endometriosis is an estrogen-dependent inflammatory
disease1 that was first described in 1860.2 It is a progres-
sive disease that affects 10% to 15% of reproductive age
women and nearly half of all infertile women. It is defined
as the presence of endometrial-like tissue outside of the
uterine cavity.3,4 The condition is commonly associated
with chronic pelvic pain and infertility.5,6 Superficial or
deep endometriosis can involve virtually any pelvic or
extrapelvic organ.7 The most common site of extragenital
endometriosis is the intestinal tract, which accounts for
approximately 80% of all extragenital endometriosis.3,4
Although bowel endometriosis may cause severe gastro-
intestinal (GI) symptoms, these disturbances are fre-
quently not adequately investigated at the time of gyne-
cologic evaluation. As a result, bowel endometriosis may
be an unexpected finding at surgery, and the lesions may
not be treated due to the lack of preoperative informed
consent or surgical inexperience.8 Moreover, the extent of
intestinal wall resection necessary to adequately treat the
disease is highly debated. Identifying high-stage and re-
current cases is critical, because they require careful sur-
gical planning.
This article will describe the clinical characteristics of
women with bowel endometriosis and will present the
results of our own experience in laparoscopic manage-
ment of the disease. We will identify possible predicting
factors for the extent of the disease and its recurrence. It is
useful for gynecologists and general surgeons to under-
stand the spectrum of intestinal tract endometriosis so as
to be able to anticipate its presence and plan accordingly.
MATERIALS AND METHODS
We reviewed the charts of all patients at our tertiary
referral center who underwent laparoscopic surgery be-
tween February 2002 and September 2009 and identified
all those with pathologically confirmed bowel endometri-
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SCIENTIFIC PAPERosis. The final cohort consisted of 193 patients. We also
reviewed the operative reports to confirm that a diagnosis
of bowel endometriosis was made during the surgery and
that endometriotic lesions were found to infiltrate beyond
the serosal layer of the intestinal wall.
We then abstracted data from the charts of all 193 patients
with respect to age, body mass index (BMI), previous
surgery, presenting symptoms and their timing, intraoper-
ative findings and procedures, sites and stage of endome-
triosis, short- and long-term follow-up and pain relief,
perioperative morbidity, and recurrence of endometriosis.
The disease was staged according to the 1996 American
Society for Reproductive Medicine classification, based on
the operative findings.9
Before surgery, each patient underwent a routine gyne-
cologic and rectovaginal examination and a transvaginal
ultrasound. Each patient also underwent mechanical
bowel preparation and received perioperative intrave-
nous antibiotics. The lesion distribution, depth of inva-
sion, and level of stricture dictated the laparoscopic
method of treatment of intestinal endometriosis. Superfi-
cial lesions that did not invade the muscularis were
shaved with CO2 laser. Disc excision was performed when
endometriotic lesions partially invaded the muscular
layer, but not the mucosa of the bowel.10–12 When infil-
trative lesions involved more than one-third of the circum-
ference of the bowel or caused partial bowel obstruction,
a segmental resection with end-to-end anastomosis was
performed. We removed all visible endometriotic foci in
other parts of the pelvis, abdomen, and thoracic cavity as
needed.13 Preoperative and intraoperative consultation
with a colorectal surgeon, urologist, or thoracic surgeon
was obtained as appropriate.
Descriptive statistics were calculated and tabulated. Nor-
mally distributed data are presented as mean  standard
deviation (SD). Associations between study outcomes and
potential predictors were explored using the independent
sample t test for continuous variables and the chi-square
test for categorical variables. A P value .05 was consid-
ered to be statistically significant. All analyses were con-
ducted using SPSS statistical software version 15 (SPSS
Inc., Chicago, IL). The Institutional Review Boards of the
Stanford University Medical Center and El Camino Hospi-
tal approved this study.
RESULTS
During the 7 and 1⁄2 year study period, 193 patients with
pathologically confirmed bowel endometriosis were
identified. The mean age of the study group was 367
years (range, 17 to 52) with a mean BMI of
23.23.1kg/m
2 (range, 18.2 to 34.3). The most common
preoperative presenting symptom was chronic pelvic
pain. At the time of presentation, 59% of patients had GI
symptoms, but only 36% (n70) included it as one of
their chief complaints. Of those with GI symptoms,
constipation and dyschezia were the most common.
Urinary frequency was the most common urinary com-
plaint at the time of presentation. A complete list of
presenting symptoms can be found in Table 1 along
with baseline characteristics. A total of 45% of patients
described their symptoms as cyclic in nature, occurring
at or around the time of menstruation. A total of 44%
(n85) had a history of laparoscopic surgery at other
medical centers; these were mainly for treatment of
endometriosis. Of patients, 11% (n22) had a history of
depression, and 6% (n11) had some type of uterine
anomaly (bicornuate or septate uterus).
Table 1.
Baseline Characteristics
Age 367 years (range, 17–52)
BMI 23.2 3.1 kg/m
2
(range, 18.2–34.3)
Presenting Symptoms No. (%)
a of Patients
Chronic pelvic pain, not
otherwise specified
159 (82)
Abnormal uterine bleeding 128 (66)
Dysmenorrhea 101 (52)
Dyspareunia 34 (18)
Gastrointestinal symptoms
(total)
70 (36)
Constipation 65 (34)
Dyschezia 54 (28)
Diarrhea 43 (22)
Nausea/vomiting 41 (21)
Melena 3 (1.6)
Urinary symptoms 55 (28)
Stage of endometriosis
Stage 1 13 (6)
Stage 2 36 (19)
Stage 3 27 (14)
Stage 4 117 (61)
aTotal 100% because most patients presented with more than
1 symptom.
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patients (Table 1). More than half of the patients (58%)
had multiple sites of intestinal endometriosis, with the
recto-sigmoid colon, recto-vaginal septum, and appendix
being the most common sites in descending order of
frequency. A total of 97% (n187) of patients also had
endometriotic lesions at sites other than the intestinal
tract, with ovaries being the most common nongastroin-
testinal site of endometriosis lesions. Coexistence of uri-
nary tract (bladder and/or ureter) endometriosis was seen in
62% (n119) of patients and was treated at the time of
surgery. The complete list of sites of endometriosis is pro-
vided in Table 2. During surgery, 11% (n22) of patients
were concomitantly diagnosed with adenomyosis.
Disc excision, segmental bowel resection, and appendec-
tomy were performed on 73% (n141), 1.6% (n3), and
37% (n72) of patients, respectively. Of 72 appendecto-
mies, pathology reports indicated an abnormal appendix
(endometriosis/fibrotic obliteration) in 65% of cases. Vary-
ing degrees of enterolysis were required in 65% (n126)
of patients. One patient underwent a combination of lap-
aroscopy for treatment of abdominopelvic endometriosis
and thoracoscopy for treatment of thoracic endometriosis.
The operative procedures performed on patients in the
study are listed in Table 3. All procedures were carried
out successfully by laparoscopy without conversion to
laparotomy. We used a combination of conventional and
robot-assisted laparoscopy in 7 cases (4%).
No major complications occurred. These were defined as
rectovaginal fistula, anastomotic leakage/stenosis, inad-
vertent ureteral damage, accidental bowel perforation,
and pelvic abscesses. Minor complications occurred in 7%
(n13) of patients and included 4 cases of transient uri-
nary retention and 9 cases of incision-site infection. All of
these minor complications were treated in an outpatient
setting. Short-term follow-up visits in the outpatient set-
ting were routinely conducted 1, 3, and 6 months postop-
eratively. Overall, 87% (n167) of the entire study group
achieved amelioration of symptoms by the end of the first
postoperative month. Long-term follow-ups were con-
Table 2.
Sites of Endometriosis (n193)
Site No. (%)
a of Patients
Intestinal Sites
Rectosigmoid Colon 144 (75)
Rectovaginal Septum 110 (57)
Appendix 47 (24)
Large Intestine, not otherwise
specified
20 (10)
Small Intestine 10 (5)
Nonintestinal Sites
Posterior cul-de-sac 90 (47)
Anterior cul-de-sac 38 (19)
Pelvic sidewall 87 (45)
Uterosacral ligaments 51 (26)
Ovaries 134 (69)
Fallopian tubes 31 (16)
Uterus 52 (27)
Ureters 84 (43)
Bladder 76 (39)
Diaphragm 15 (8)
Vagina 3 (1.6)
Cervix 3 (1.6)
Liver 3 (1.6)
Inguinal canal 2 (1)
aTotal 100% because most patients had more than 1 site of
endometriosis.
Table 3.
Laparoscopic Procedures Performed (n193)
Procedure No. (%)
a of
patients
Treatment of superficial endometriosis 193 (100)
Disc excision 141 (73)
Segmental bowel resection 3 (1.6)
Appendectomy 72 (37)
Enterolysis 126 (65)
Ovarian cystectomy 86 (45)
Salpingo-oophorectomy 22 (11)
Hysterectomy 13 (7)
Myomectomy 56 (29)
Cystoscopy 139 (72)
Ureterolysis 148 (76)
Partial vaginectomy 1 (0.5)
Presacral neurectomy 6 (3)
Thoracoscopy for treatment of diaphragmatic
endometriosis
1 (0.5)
Robot-assisted laparoscopy 7 (4)
aTotal 100% because all patients had more than 1 procedure
performed.
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basis. During 1 to 8 years of long-term follow-up (mean,
4.5 years), 10% (n19) had recurrence of endometriosis
that necessitated a second laparoscopic intervention. Sim-
ilarly to their initial laparoscopic evaluation, the majority
of patients with recurrent cases were diagnosed with mul-
tiple sites of endometriosis at the time of the second
surgery. The 3 most common sites of recurrent endome-
triosis in decreasing order of frequency were genital tract
(8%), urinary tract (6%), and GI tract (4%).
We divided our cohort into 2 groups for further analysis: 1
group with lower-stage endometriosis (stages I, II, & III) and
1 group with high-stage endometriosis (stage IV). There
were 2 preoperative factors significantly related to higher
stage disease: a presenting complaint of abnormal uterine
bleeding (P.01) or a history of laparoscopic surgery
(P.04). There was also a significant association between
the stage of endometriosis and some of the operative pro-
cedures performed. Patients with stage IV endometriosis
were more likely to need enterolysis (P.002), ovarian cys-
tectomy (P.001), and segmental bowel resection/disc ex-
cision (P.01) performed during their surgeries, as com-
pared with those with less advanced stages of disease.
Coexistent urinary tract endometriosis was significantly more
likely in patients with more advanced stages of endometri-
osis (P.02). A complete list of variables and their associa-
tions with stage of endometriosis is shown in Table 4.N o
significant associations were noted between the stage of
endometriosis and the patients’ BMI, type of surgery (con-
ventional vs. robot-assisted laparoscopy), or frequency of
postoperative complications.
We conducted a subanalysis of 19 patients with recurrent
endometriosis to identify possible predictors of recurrent
disease. Patients with higher BMI had significantly higher
recurrence rate of endometriosis compared to those with
lower BMI (P.002). No significant correlations existed
between recurrence rate and age, presenting symptoms,
or history of previous laparoscopic surgery. Although a
higher recurrence rate was seen in patients with stage IV
endometriosis compared to patients with less advanced
stages, the relationship did not reach statistical signifi-
cance. There was no significant difference between recur-
rence rate and the type of surgery performed (conven-
tional vs. robot-assisted laparoscopy).
Table 4.
Variables Associated with Stage of Endometriosis
Low Stage (I, II, & III) High Stage (IV) P Value
Age 35  7.6 35.8  6.2 .4
BMI 23  3.3 23.3  3.1 .6
Presenting with irregular bleeding 59% 70% .04
Presenting with GI symptoms 34% 41% .4
Presenting with urinary symptoms 32% 30% .7
Depression 10% 12% .8
Uterine anomalies 4% 7% .7
Past laparoscopy 29% 53% .003
Ovarian cystectomy performed during surgery 24% 57% .001
Enterolysis performed during surgery 51% 79% .001
Myomectomy performed during surgery 35% 27% .2
Hysterectomy performed during surgery 6% 8% .7
Appendectomy performed during surgery 35% 41% .5
Segmental bowel resection/Disc excision performed during surgery 40% 85% .01
Presacral neurectomy performed during surgery 0% 5% .1
Endometriosis of appendix 22% 28% .4
Endometriosis of urinary tract 51% 70% .02
Concomitant adenomyosis 6% 13% .1
Recurrence of endometriosis 7% 11% .4
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Bowel endometriosis was first described in 1922 by Samp-
son.14 It affects between 3% and 37% of patients with a
diagnosis of endometriosis. It can present at any level
from the anal canal to the small intestine; however, the
most frequent locations of involvement are the rectum
and sigmoid colon.3,4,15,16 Intestinal implantation begins
on the serosa and sometimes invades the muscularis pro-
pria but rarely affects the mucosa.4,8,17
Patients with endometriosis present with different clinical
complaints at various stages of disease.5 The majority of
those with bowel involvement develop a variety of GI
complaints including constipation, diarrhea, abdominal
bloating, tenesmus, lower abdominal pain, and occasion-
ally rectal bleeding.3,5,8 Symptoms usually occur cyclically
at or about the time of menstruation.5 Appendiceal endo-
metriosis can mimic acute appendicitis, or it may contrib-
ute to chronic pelvic pain.18–23 Bowel obstruction is a rare
complication that can be confused with carcinoma3,17,24
The differential diagnosis of bowel endometriosis in-
cludes irritable bowel syndrome, inflammatory bowel dis-
ease, diverticulitis, and bowel carcinoma.8,17,25
Several techniques have been proposed to aid in the
diagnosis of bowel endometriosis. These include barium
enema, transvaginal ultrasound, transrectal ultrasound,
colonoscopy, computed tomography, and magnetic reso-
nance imaging.8 Although studies have shown varying
levels of success using these methodologies,23,26–28 it is
generally believed that they are of little diagnostic
value.3,7,29,30 In short, no clear guidelines exist for the
evaluation of patients with suspected bowel endome-
triosis. When clinical evidence suggests the presence of
deeply infiltrating endometriosis, we use imaging stud-
ies to map the extent of disease. Nevertheless, laparo-
scopic assessment in combination with histological ex-
amination of excised lesions remains the gold standard
for diagnosis of any type of endometriosis including
that of the bowel.4–5,30
Historically, 2 major approaches exist for management of
bowel endometriosis: medical and surgical. Medical treat-
ments are focused on hormonal manipulation of the men-
strual cycle in an attempt to produce a pseudo-pregnancy,
pseudo-menopause, or chronic anovulation.6 Alterna-
tively, targeting aromatase, cyclooxygenase-2, estrogen
receptor , or progesterone receptors may reduce pelvic
pain and decrease visible endometriotic tissue.31–33 Al-
though hormonal modulation may be useful in some set-
tings like preoperative preparation,23,34–35 it rarely yields
satisfactory long-term results.5,8,36,37 This may be because
of fibrotic changes and scar tissue, resulting in pelvic pain
that is refractory to medical therapy.3 Currently, surgical
removal of endometriotic lesions appears to be the most
effective treatment, because it is associated with a signif-
icant improvement in pain, quality of life, and fertility
status.8,38,39
Successful laparoscopic bowel resection for the treatment
of bowel endometriosis was first described in 1988.10,40,41
Over the last 2 decades, a variety of laparoscopic tech-
niques have proven effective in the treatment of intestinal
endometriosis. These include laser vaporization, shaving,
disc excision, segmental bowel resection, and appendec-
tomy, all of which can be performed successfully via
laparoscopy.11,12
Advances in laparoscopic management of severe bowel
endometriosis would not have been possible without mul-
tiple advances in instrumentation and the introduction of
videolaparoscopy.42–45 Before the introduction of video-
laparoscopy, the utility of operative laparoscopy was di-
minished by two major drawbacks: poor visualization into
the intra-abdominal cavity with one eye and the inability
of the operative team to view the operative field. Both of
these limitations were rectified with the incorporation of
the videolaparoscope.43,44 These advances made it possi-
ble to treat even the most extensive pathology laparo-
scopically.
Several authors agree that laparoscopic bowel resection is
feasible and can be performed safely when needed.46–49
However, a debate exists regarding the extent of intestinal
wall resection necessary to adequately treat the disease.36
Segmental bowel resection represents the most radical
approach but is characterized by a specific pattern of
major postoperative complications and lower pregnancy
rates compared with less aggressive methods, such as disc
excision.11,12,50 Those in favor of segmental resection ar-
gue that the wide margin of excision achieved results in a
lower recurrence rate of the endometriosis.37,51–53 How-
ever, the dissection necessary to achieve mobilization for
a segmental bowel resection poses a greater risk of inad-
vertent trauma to the superior and especially inferior hy-
pogastric plexus. Injury to these plexus could cause per-
sistent bowel and urinary symptoms postoperatively.
The majority of our patients were managed without seg-
mental bowel resection. They achieved high levels of pain
relief and excellent long-term outcome with low recur-
rence rates and no major complications. Because colorec-
tal endometriosis is considered a benign disease,22 we feel
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resort, appropriate only for those with lesions involving
more than one-third of the circumference of the bowel or
those with partial bowel obstruction. In addition, intraop-
erative proctosigmoidoscopy should be performed when
necessary. This procedure has been shown to be effective
in assessment of bowel wall invasion, detecting bowel
injuries during laparoscopy and evaluating anastomosis.54
Similarly to other studies,55 we found that concomitant
genital and urinary tract endometriosis are frequently seen
in patients with bowel endometriosis. Therefore, a careful
and systematic inspection of the pelvic and abdominal
cavity is necessary to detect and treat all possible lesions.
Moreover, in findings that echo those of Redwine and
Chapron et al,56,57 we found that a large portion of our
patients had multifocal endometriosis lesions of the intes-
tines; however, in contrast to their opinions, we believe
that even multifocal cases of bowel endometriosis can be
managed successfully by laparoscopy with no need for
conversion to laparotomy.
We found that obese or overweight women had a signif-
icantly higher rate of recurrence compared with patients
with normal BMI. It is unlikely that the higher recurrence
rate in this subgroup is due to incomplete treatment of
endometriosis, as it has been demonstrated that laparo-
scopic approach in treatment of endometriosis is not sig-
nificantly influenced by BMI in terms of surgical outcome
or complications rate.58 Instead, this could be partly due to
the fact that obese women have more adipose tissue and
consequently higher output of estrogen produced by the
aromatase activity in those tissues. This would be consis-
tent with the estrogen-dependent nature of the disease.
However, we did not find any significant association be-
tween BMI and disease stage.
Although not clinically specific, we demonstrated 2 statis-
tically significant preoperative predictors of severe dis-
ease: a presenting complaint of abnormal uterine bleed-
ing, a history of gynecologic laparoscopy, or both of
these.
Our study has several limitations. Our center is a tertiary
referral center for endometriosis; therefore, our patients
may not be representative of the population as a whole.
The retrospective nature of this study limited our ability to
control for confounding factors and thus limited our abil-
ity to reliably predict those factors that lead to recurrence.
All the presenting symptoms in our study were self-re-
ported. Our study was limited to patients with proven
bowel endometriosis, so we were not able to determine
how valuable GI symptoms may be in predicting the
presence of bowel endometriosis. To determine the pre-
dictive nature of gastrointestinal symptoms and ade-
quately compare disc excision to segmental bowel resec-
tion for treatment of bowel endometriosis, further
prospective controlled trials are warranted. We also be-
lieve that, based on our findings in terms of relation
between higher BMI and higher rate of recurrence, future
studies are required to investigate the association between
preoperative estrogen levels and recurrence of endome-
triosis.
CONCLUSION
Intestinal endometriosis should be suspected in women
of childbearing age who present with gastrointestinal
symptoms and a history of endometriosis. High-stage
and recurrent cases necessitate careful surgical plan-
ning. Our study confirms that laparoscopic manage-
ment of bowel endometriosis is feasible, safe, and effi-
cient. All patients who undergo laparoscopy for
treatment of endometriosis or chronic pelvic pain
should be counseled regarding the possibility of bowel
involvement and the risk, benefits, and alternatives of
treatment. Although it may be technically demanding,
removal of endometriotic lesions is critical for symp-
tomatic relief and if carried out in specialist centers by
surgeons with proper training and experience, leads to
positive results with minimal morbidity.
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